Clinical Trials Directory

Trials / Unknown

UnknownNCT02062216

Role of the Inflammatory Receptors in the Pathogenesis of Atherosclerosis

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
University of Roma La Sapienza · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to assess whether inflammatory receptors play a role in the pathogenesis of atherosclerosis.

Detailed description

Atherosclerosis is a chronic inflammatory disease characterized by lipid deposition and macrophages/foam cell accumulation beneath the arterial intima. Immune competent cells are abundant in atherosclerotic lesions, where they produce mainly proinflammatory cytokines. Macrophages play a central role in each stage of the pathogenesis of atherosclerosis. At the beginning, the so-called foam cells contribute to the formation of early lesions; in mature plaques, macrophages constitute 50% of the cells in the lesion; finally, they are involved in the mechanisms leading to plaque rupture. The primary objective of this study is to assess whether the inflammatory receptors play a role in the pathogenesis of atherosclerosis.

Conditions

Timeline

Start date
2015-02-01
Primary completion
2017-12-01
Completion
2018-12-01
First posted
2014-02-13
Last updated
2014-03-14

Source: ClinicalTrials.gov record NCT02062216. Inclusion in this directory is not an endorsement.

Role of the Inflammatory Receptors in the Pathogenesis of Atherosclerosis (NCT02062216) · Clinical Trials Directory